Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy (2009)
- Authors:
- Folgueira, Maria Aparecida Azevedo Koike
- Brentani, Helena
- Carraro, Dirce Maria
- Barros Filho, Mateus de Camargo
- Katayama, Maria Lucia Hirata
- Abreu, Ana Paula Santana de
- Barbosa, Edson Mantovani
- Oliveira, Célia Tosello de
- Patrão, Diogo F. C.
- Mota, Louise D.
- Mourão Netto, Mario
- Caldeira, José Roberto Figaro
- Brentani, Maria Mitzi
- USP affiliated authors: FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - FM ; KATAYAMA, MARIA LUCIA HIRATA - FM ; BRENTANI, MARIA MITZI - FM
- Unidade: FM
- DOI: 10.3892/or_00000503
- Subjects: EXPRESSÃO GÊNICA; NEOPLASIAS MAMÁRIAS; QUIMIOTERAPIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Oncology reports
- ISSN: 1021-335X
- Volume/Número/Paginação/Ano: v. 22, n. 4, p. 805-813, 2009
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FOLGUEIRA, Maria Aparecida Azevedo Koike et al. Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy. Oncology reports, v. 22, n. 4, p. 805-813, 2009Tradução . . Disponível em: https://doi.org/10.3892/or_00000503. Acesso em: 17 fev. 2026. -
APA
Folgueira, M. A. A. K., Brentani, H., Carraro, D. M., Barros Filho, M. de C., Katayama, M. L. H., Abreu, A. P. S. de, et al. (2009). Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy. Oncology reports, 22( 4), 805-813. doi:10.3892/or_00000503 -
NLM
Folgueira MAAK, Brentani H, Carraro DM, Barros Filho M de C, Katayama MLH, Abreu APS de, Barbosa EM, Oliveira CT de, Patrão DFC, Mota LD, Mourão Netto M, Caldeira JRF, Brentani MM. Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy [Internet]. Oncology reports. 2009 ; 22( 4): 805-813.[citado 2026 fev. 17 ] Available from: https://doi.org/10.3892/or_00000503 -
Vancouver
Folgueira MAAK, Brentani H, Carraro DM, Barros Filho M de C, Katayama MLH, Abreu APS de, Barbosa EM, Oliveira CT de, Patrão DFC, Mota LD, Mourão Netto M, Caldeira JRF, Brentani MM. Gene expression profile of residual breast cancer after doxorubicin and cyclophosphamide neoadjuvante chemotherapy [Internet]. Oncology reports. 2009 ; 22( 4): 805-813.[citado 2026 fev. 17 ] Available from: https://doi.org/10.3892/or_00000503 - Bone Marrow Micrometastasis is not Related to Lymph Node Involvement in Breast Cancer
- Gene profile of fibroblasts from involved and uninvolved lymph nodes from breast cancer patients and influence of malignant cancer cells on their gene expression
- Expression of PRSS11, CLPTM1, SMD2, in slices of bitch mammary cancer and correlation with response to exposure doxorubicin in vitro
- G3BP2 and GPRC5A mRNA Expression in Oral Squamous Cell Carcinoma
- Influence of fibroblasts originated from breast cancer and normal adjacent tissue from benign disease on gene expression profile of normal and tumoral epithelial mammary cells
- Expression of heterochromatin protein 1 in the primary tumor of breast cancer patients in the presence or absence of occult metastatic cells in the bone marrow
- Gene expression of residual breast cancer after primary chemotherapy based on doxorubicin
- Vitamin D system is altered in breast cancer patients
- Influence of malignant breast cancer cell on the gene expression of fibroblasts obtained from involved [FN(+)]or uninvolved [FN(-)] lymph nodes of breast cancer patient
- Transcriptional profile and response to neoadjuvant chemotherapy in breast cancer
Informações sobre o DOI: 10.3892/or_00000503 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
